Growth Metrics

Novartis Ag (NVS) Non-Current Assets (2016 - 2025)

Novartis Ag's Non-Current Assets history spans 12 years, with the latest figure at $80.5 billion for Q4 2025.

  • On a quarterly basis, Non-Current Assets rose 10.96% to $80.5 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $80.5 billion, a 10.96% increase, with the full-year FY2025 number at $80.5 billion, up 10.96% from a year prior.
  • Non-Current Assets hit $80.5 billion in Q4 2025 for Novartis Ag, up from $78.5 billion in the prior quarter.
  • Over the last five years, Non-Current Assets for NVS hit a ceiling of $86.1 billion in Q4 2021 and a floor of $57.5 billion in Q2 2021.
  • Historically, Non-Current Assets has averaged $75.9 billion across 5 years, with a median of $78.0 billion in 2023.
  • Biggest five-year swings in Non-Current Assets: soared 47.42% in 2022 and later fell 13.76% in 2023.
  • Tracing NVS's Non-Current Assets over 5 years: stood at $86.1 billion in 2021, then fell by 6.43% to $80.5 billion in 2022, then fell by 13.76% to $69.5 billion in 2023, then grew by 4.43% to $72.5 billion in 2024, then increased by 10.96% to $80.5 billion in 2025.
  • Business Quant data shows Non-Current Assets for NVS at $80.5 billion in Q4 2025, $78.5 billion in Q2 2025, and $72.5 billion in Q4 2024.